Rabies is a viral disease that causes inflammation of the brain in humans and other mammals. Early symptoms can include fever and tingling at the site of exposure. These symptoms are followed by one or more of the following symptoms: violent movements, uncontrolled excitement, fear of water, an inability to move parts of the body, confusion, and loss of consciousness. Once symptoms appear, the result is nearly always death. The time period between contracting the disease and the start of symptoms is usually one to three months, but can vary from less than one week to more than one year. The time depends on the distance the virus must travel along peripheral nerves to reach the central nervous system.

Market Analysis and Insights: Global Rabies Diagnostics Market
The global Rabies Diagnostics market size is projected to reach US$ 2128 million by 2027, from US$ 1739.3 million in 2020, at a CAGR of 2.5% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Rabies Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Rabies Diagnostics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Rabies Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Rabies Diagnostics market.

Global Rabies Diagnostics Scope and Market Size
Rabies Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Rabies Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Enzyme-Linked Immunosorbent Assay (ELISA)
Polymerase Chain Reaction (PCR) Assay
Others

Segment by Application
Hospitals
Diagnostic Centers
Public Health Labs
Home Care Setting

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Bio-Rad Laboratories
Merck
Thermo Fisher
Roche
BioMerieux
QIAGEN
Agilent
Creative Diagnostics
Techne
Fluidigm
Abbexa Ltd
BioNote, Inc
Norgen Biotek Corp
Aviva Systems Biology
Demeditec Diagnostics GmbH
Express Biotech International